RAD140 - CAS 1182367-47-0
Catalog number: B0084-457306
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
COA:
Certificate of Analysis-RAD140 1182367-47-0 B16Q120401  
Targets:
Androgen Receptor
Description:
RAD140, an effective non-steroidal selective androgen receptor modulator, could probably stimulate the increasing of muscle and also has been found to have potential neuroprotective properties in hippocampal neurons. It was just planed a trial for Breast
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-457306 1 g $290 In stock
B0084-457306 50 g $1499 In stock
Bulk Inquiry
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥ 98.0%
Appearance:
White to off-white powder
Synonyms:
2-Chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile;RAD 140
Solubility:
10 mM in DMSO
Storage:
Stored at -20°C.
MSDS:
Inquire
Application:
RAD140 is an effective non-steroidal selective androgen receptor modulator which could probably stimulate the increasing of muscle and also has been found to have potential neuroprotective properties in hippocampal neurons.
Quality Standard:
In-house Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
687.7±65.0 °C | Condition: Press: 760 Torr
Density:
1.41 g/cm3
InChIKey:
XMBUPPIEVAFYHO-KPZWWZAWSA-N
InChI:
1S/C20H16ClN5O2/c1-11-16(8-7-15(10-23)17(11)21)24-18(12(2)27)20-26-25-19(28-20)14-5-3-13(9-22)4-6-14/h3-8,12,18,24,27H,1-2H3/t12-,18+/m0/s1
Canonical SMILES:
CC1=C(C=CC(=C1Cl)C#N)NC(C2=NN=C(O2)C3=CC=C(C=C3)C#N)C(C)O
Current Developer:
Radius
1.Translational Highlights
HORM CANC (2014) 5:113–123
The decline in testosterone levels in men during normal aging increases risks of dysfunction and disease in androgenresponsive tissues, including brain. The use of testosterone therapy has the potential to increase the risks for developing prostate cancer and or accelerating its progression. To overcome this limitation, novel compounds termed selective androgen receptor modulators (SARMs) have been developed that lack significant androgen action in prostate but exert agonist effects in select androgen-responsive tissues. The efficacy of SARMs in brain is largely unknown. In this study, we investigate the SARM RAD140 in cultured rat neurons and male rat brain for its ability to provide neuroprotection, an important neural action of endogenous androgens that is relevant to neural health and resilience to neurodegenerative diseases. In cultured hippocampal neurons, RAD140 was as effective as testosterone in reducing cell death induced by apoptotic insults. Mechanistically, RAD140 neuroprotection was dependent upon MAPK signaling, as evidenced by elevation of ERK phosphorylation and inhibition of protection by the MEK inhibitor U0126. Importantly, RAD140 was also neuroprotective in vivo using the rat kainate lesion model. In experiments with gonadectomized, adult male rats, RAD140 was shown to exhibit peripheral tissue-specific androgen action that largely spared prostate, neural efficacy as demonstrated by activation of androgenic gene regulation effects, and neuroprotection of hippocampal neurons against cell death caused by systemic administration of the excitotoxin kainate. These novel findings demonstrate initial preclinical efficacy of a SARM in neuroprotective actions relevant to Alzheimer’s disease and related neurodegenerative diseases. This article appears in Endocrinology.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Androgen Receptor Products


ASC-J9
(CAS: 52328-98-0)

ASC-J9 is an AR degradation enhancer, suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen rece...

LGD-4033 (Ligandrol)
(CAS: 1165910-22-4)

LGD-4033, also known as VK5211 and Ligandrol, is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wast...

CAS 19608-29-8 Cortexolone 17 alpha-propionate

Cortexolone 17 alpha-propionate
(CAS: 19608-29-8)

Cortexolone 17 alpha-propionate, also called as CB-03-01, belonging to the family of ester derivatives of cortexolone, is a potent and topical and peripherally ...

CAS 90357-06-5 Bicalutamide

Bicalutamide
(CAS: 90357-06-5)

Bicalutamide is a non-steroidal androgen receptor (AR) antagonist with IC50 of 0.16 μM.

ODM-201
(CAS: 1297538-32-9)

ODM-201 is a new-generation, potent and selective androgen receptor (AR) inhibitor which is potential useful for treatment of castration-resistant prostate canc...

CAS 606101-58-0 MK-0773

MK-0773
(CAS: 606101-58-0)

MK-0773 is a selective androgen receptor modulator for the prevention and treatment of muscle wasting associated with cancer. It designed to improve muscle func...

GLPG0492 R enantiomer
(CAS: 1215085-93-0)

The R-enantiomer of GLPG0492 which is a selective androgen receptor modulator, could be effective in decreasing muscle loss.

CH5137291
(CAS: 1043446-39-4)

CH5137291 is a potent androgen receptor (AR) pure antagonist which did not produce the agonist metabolite with AR nuclear translocation-inhibiting activity. It ...

CAS 3546-41-6 Pyrvinium pamoate

Pyrvinium pamoate
(CAS: 3546-41-6)

Pyrvinium pamoate, a nonabsorbed anthelmintic drug, is a potent androgen receptor inhibitor and a selective WNT pathway inhibitor. Pyrvinium pamoate is a potent...

CAS 956104-40-8 Apalutamide

Apalutamide
(CAS: 956104-40-8)

Apalutamide is a potent and competitive androgen receptor (AR) antagonist with potential antineoplastic activity. It binds to AR in target tissues thereby preve...

CAS 1076225-27-8 PF 998425

PF 998425
(CAS: 1076225-27-8)

PF 998425 is a novel, nonsteroidal androgen receptor (AR) antagonist (IC50= 26 nM and 90 nM in AR binding assays and cellular assays respectively) for sebum con...

MI-136
(CAS: 1628316-74-4)

MI-136, with the potential to treat refractory prostate cancer, inhibits DHT-induced expression of androgen receptor (AR) target genes. In vitro: Treatment with...

LGD-2226
(CAS: 328947-93-9)

LGD-2226 is a selective androgen receptor modulator used in the treatment of muscle wasting and osteoporosis, shows to have an anabolic effect on muscle and bon...

CAS 915087-27-3 RD 162

RD 162
(CAS: 915087-27-3)

RD 162 is an orally bioactive and second-generation antagonist of androgen receptor (AR). It inhibits 18F-FDHT binding to AR in human prostate cancer cells thus...

CAS 1240299-33-5 AZD-3514

AZD-3514
(CAS: 1240299-33-5)

AZD-3514 is a potent androgen receptor downregulator with potential anticancer cancer activity. AZD3514 is being evaluated in a Phase I clinical trial in patie...

CAS 427-51-0 Cyproterone acetate

Cyproterone acetate
(CAS: 427-51-0)

Cyproterone acetate is a synthetic derivative of 17-hydroxyprogesterone, and acts as an androgen receptor antagonist as well as a weak progesterone receptor ago...

CAS 1182367-47-0 RAD140

RAD140
(CAS: 1182367-47-0)

RAD140, an effective non-steroidal selective androgen receptor modulator, could probably stimulate the increasing of muscle and also has been found to have pote...

MK-3984
(CAS: 871325-55-2)

MK-3984 is a androgen receptor modulators. It can be used for the prevention and treatment of muscle wasting associated with cancer.

JNJ-26146900
(CAS: 868691-50-3)

JNJ-26146900 is a selective, nonsteroidal androgen receptor modulator with tissue-selective activity in rats. It can bind to the rat AR with a Ki of 400nM and a...

CAS 643094-49-9 Fasobegron

Fasobegron
(CAS: 643094-49-9)

Fasobegron acts a β3-adrenoreceptor agonist.

Chemical Structure

CAS 1182367-47-0 RAD140

Quick Inquiry

Verification code

Featured Items